Canada markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.1300-0.1200 (-5.33%)
At close: 04:00PM EDT
2.1699 +0.04 (+1.87%)
After hours: 07:53PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 403.55M
Enterprise Value 445.93M
Trailing P/E N/A
Forward P/E 9.26
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.21
Price/Book (mrq)74.89
Enterprise Value/Revenue 1.94
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.89
52-Week Change 352.14%
S&P500 52-Week Change 326.14%
52 Week High 33.4000
52 Week Low 30.7000
50-Day Moving Average 32.3026
200-Day Moving Average 31.8552

Share Statistics

Avg Vol (3 month) 37.41M
Avg Vol (10 day) 36.76M
Shares Outstanding 5189.46M
Implied Shares Outstanding 6200.41M
Float 8174.52M
% Held by Insiders 10.45%
% Held by Institutions 166.46%
Shares Short (Apr 30, 2024) 419.87M
Short Ratio (Apr 30, 2024) 42.79
Short % of Float (Apr 30, 2024) 410.60%
Short % of Shares Outstanding (Apr 30, 2024) 410.58%
Shares Short (prior month Mar 28, 2024) 419.92M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -37.65%
Operating Margin (ttm)52.47%

Management Effectiveness

Return on Assets (ttm)-6.94%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)229.74M
Revenue Per Share (ttm)1.83
Quarterly Revenue Growth (yoy)466.10%
Gross Profit (ttm)N/A
EBITDA -34.56M
Net Income Avi to Common (ttm)-86.51M
Diluted EPS (ttm)-0.9000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)226.61M
Total Cash Per Share (mrq)1.2
Total Debt (mrq)548.87M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.22
Book Value Per Share (mrq)-1.57

Cash Flow Statement

Operating Cash Flow (ttm)-27.3M
Levered Free Cash Flow (ttm)-45.36M